Abstract Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal branched‐chained amino acid (BCAA)‐to‐aromatic amino acid (AAA) ratio being the most common abnormality. Different liver diseases have distinctive amino acid profiles. Objectives Determine the changes in plasma amino acid profiles in dogs with extrahepatic portosystemic shunts (EHPSS) from diagnosis to complete closure. Animals Ten client‐owned dogs with EHPSS closed after surgical attenuation. Methods Prospective cohort study. Medical treatment was instituted in dogs diagnosed with EHPSS. At least 4 weeks later, gradual surgical attenuation was performed. Three months postoperatively, EHPSS closure was confirmed by transsplenic por...
Background Diagnosing a congenital portosystemic shunt (cPSS) in dogs can be challenging. The curren...
Hepatopathies can cause major metabolic abnormalities in humans and animals. This study examined dif...
Background: In dogs with portosystemic shunting (PSS) or chronic liver disease metabolic functions o...
Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal...
Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal...
Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal...
In humans, chronic liver disease may cause alterations in amino acids (AAs) metabolism, with serum b...
In dogs with reduced liver function (portosystemic shunting, parenchymal liver disease), metabolic f...
Background Metabolomic analysis using blood samples has been suggested to be useful for the early de...
Liver disease is a major cause of morbidity and mortality. One of the most significant complications...
Objective To determine the sensitivity and specificity of different individual and combined blood te...
Abstract In dogs with a congenital portosystemic shunt (CPSS), the outcome after CPSS attenuation is...
Abstract Background Chronic hepatopathies present a diagnostic challenge, with different diseases be...
Abstract In dogs with a congenital portosystemic shunt (CPSS), the outcome after CPSS attenuation is...
Liver disease is a major cause of morbidity and mortality. One of the most significant complications...
Background Diagnosing a congenital portosystemic shunt (cPSS) in dogs can be challenging. The curren...
Hepatopathies can cause major metabolic abnormalities in humans and animals. This study examined dif...
Background: In dogs with portosystemic shunting (PSS) or chronic liver disease metabolic functions o...
Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal...
Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal...
Background Dogs with portosystemic shunts have an altered blood amino acid profile, with an abnormal...
In humans, chronic liver disease may cause alterations in amino acids (AAs) metabolism, with serum b...
In dogs with reduced liver function (portosystemic shunting, parenchymal liver disease), metabolic f...
Background Metabolomic analysis using blood samples has been suggested to be useful for the early de...
Liver disease is a major cause of morbidity and mortality. One of the most significant complications...
Objective To determine the sensitivity and specificity of different individual and combined blood te...
Abstract In dogs with a congenital portosystemic shunt (CPSS), the outcome after CPSS attenuation is...
Abstract Background Chronic hepatopathies present a diagnostic challenge, with different diseases be...
Abstract In dogs with a congenital portosystemic shunt (CPSS), the outcome after CPSS attenuation is...
Liver disease is a major cause of morbidity and mortality. One of the most significant complications...
Background Diagnosing a congenital portosystemic shunt (cPSS) in dogs can be challenging. The curren...
Hepatopathies can cause major metabolic abnormalities in humans and animals. This study examined dif...
Background: In dogs with portosystemic shunting (PSS) or chronic liver disease metabolic functions o...